primary antibodies against pcna ag8029 (Beyotime)
Beyotime is a verified supplier 
Beyotime manufactures this product 
90
Structured Review
Beyotime
primary antibodies against pcna ag8029
Primary Antibodies Against Pcna Ag8029, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+pcna+ag8029/primary+antibodies+against+pcna+ag8029/pm40414009-93-21-24
Average 90 stars, based on 1 article reviews
Primary Antibodies Against Pcna Ag8029, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+pcna+ag8029/primary+antibodies+against+pcna+ag8029/pm40414009-93-21-24
Average 90 stars, based on 1 article reviews
primary antibodies against pcna ag8029 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: IRF2-driven upregulation of OAS3 promotes AML cell proliferation by modulating the JAK-STAT signaling pathway. Article Snippet: Acute myeloid leukemia (AML) presents significant treatment challenges due to its heterogeneity and resistance to conventional therapies.. This study explored the role of 2′-5′-oligoadenylate synthetase 3 (OAS3) in AML progression and its potential as a prognostic and therapeutic biomarker.. Through bioinformatics analysis, OAS3 was found to be significantly upregulated in AML patients and associated with poor clinical outcomes. |